CD21 Antibody

About the Target

CD21 (Complement receptor type 2) also known as (CR2) , is a surface glycoprotein primarily expressed on mature B cells and follicular dendritic cells, playing a key role in bridging innate and adaptive immunity. Structurally, it consists of 15-16 short consensus repeats (SCRs), with the N-terminal SCR1 and SCR2 mediating interactions with complement components like C3d, iC3b, and C3dg, as well as the Epstein-Barr virus (EBV) glycoprotein gp350/220.

Reported cellular context includes cell membrane and membrane, which can matter when signal is compared across treatments or changing cell states. Following CD21 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CD21 is commonly interpreted in the context of immunology, infectious disease, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane and membrane across matched conditions
• context differences tied to immune-cell state, activation, or lineage composition
• host-response changes during infection or pathogen-associated stimulation
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CD21. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CD21 reflect biology rather than handling. When interpreting CD21, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CD21 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.